白三烯受体拮抗剂在支气管哮喘中的应用前景

被引:6
作者
王曾礼
机构
[1] 华西医科大学附属第一医院呼吸内科!成都,
关键词
支气管哮喘; 白三烯受体; 组胺; 哮喘; 咪唑乙胺; 咪唑; 白三烯; 哮喘发病; 气道高反应性; 气道反应性; 嗜酸细胞; 支气管痉挛; 支气管疾病; 受体拮抗剂;
D O I
暂无
中图分类号
R562.25 [];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:379 / 381
页数:3
相关论文
共 17 条
[1]  
a novel leukotriene receptor antagonist: results of the first European,placebo controlled, multicenter clinical study in asthma. Barnes NC,Pranlukast. Thorax . 1997
[2]  
Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma. Reiss TF,Chervinsky P,Dockhorm RJ,et al. Archives of Internal Medicine . 1998
[3]  
Signal transduction processes for the LTD4 receptor. Crooke ST,Sarau H,Saussy D,et al. Adv Prostaglandin Thromboxane Leukot Res . 1990
[4]  
Worldwide clinical experience with the first marketed leukotriene receptor antagonist. Barnes NC,Bert de Jong,Miyamoto T. Chest . 1997
[5]  
Respiratory medicine no cures but some advances. Britton J,Knox A. The Lancet . 1997
[6]  
Leuakotriene modifiers in the treatment of asthma. Holgate S. British Medical Journal . 1998
[7]  
Pharmacology of leukotriene receptor antagonists. Hay DWP. Chest . 1997
[8]  
Clinical aspects of allergic disease: urinary leukotriene E4 in the assessment of nocturnal asthma. Bellia V,Bonanno A,Cibella F,et al. The Journal of Allergy and Clinical Immunology . 1996
[9]  
Leukotrienes in the pathogenesis of asthma. O’Byme PM. Chest . 1997
[10]  
Generation of leukotriene B4 and C4 from granulocytes of normal controls.allergic rhinitis and asthmatic subjects. Kohi F,Miyagawa H,Agrawal DK,et al. Annals of Allergy . 1990